Chamomile tea tied to lower thyroid cancer risk
(Reuters Health) – Consumption of chamomile tea was linked with a lower risk of thyroid cancer in a small Greek study. Researchers interviewed some Athens residents about their lifestyle, eating […]
About Reuters Health
This author has yet to write their bio.Meanwhile lets just say that we are proud Reuters Health contributed a whooping 7739 entries.
Entries by Reuters Health
Sexual dysfunction may accompany PTSD
(Reuters Health) – Men and women with post-traumatic stress disorder (PTSD) may also experience sexual dysfunction and relationship difficulties, a new research review suggests. “Persons with PTSD often complain of […]
MMR vaccine not linked to autism, even in high-risk kids
(Reuters Health) – The measles, mumps and rubella (MMR) vaccine is not linked to development of autism spectrum disorders, even among children considered to be at risk, a large new […]
Indian parliamentary committee recommends price caps for all drugs
(Reuters) – An Indian parliamentary committee has recommended that price caps should be extended to all drugs in the country and that the government should expedite the capping process. Indian […]
Belgium, Netherlands plan joint purchase of rare disease drugs
(Reuters) – Belgium and the Netherlands will jointly negotiate the purchase of remedies for rare diseases with pharmaceutical groups, the Belgian health ministry said on Tuesday. The joint negotiations will […]
Israel’s BrainStorm says stem cell drug benefits ALS patients
(Reuters) – Israel’s BrainStorm Cell Therapeutics said a mid-stage clinical trial of its adult stem cell treatment showed a “statistically significant” effect in patients with amyotrophic lateral sclerosis (ALS). According […]
AstraZeneca drug Lynparza shows promise in prostate cancer trial
(Reuters) – AstraZeneca’s recently approved ovarian cancer drug Lynparza, or olaparib, can also help men with prostate cancer, according to new clinical trial results on Tuesday. The news is the […]
Generic drugmaker Teva bids $40 billion for rival Mylan
(Reuters) – Generic drugmaker Teva Pharmaceutical Industries Ltd. on Tuesday proposed buying smaller rival Mylan for $40 billion, saying it was a better deal than Mylan’s alternate offer to buy […]
Teva to pay $512 million to settle claims of delayed generic Provigil
(Reuters) – Teva Pharmaceutical Industries Ltd has agreed to pay $512 million to settle a class action claiming that Cephalon Inc, which Teva bought in 2011, used anticompetitive settlements to […]
Lilly’s psoriatic arthritis drug succeeds in late-stage study
(Reuters) – Eli Lilly and Co said its experimental drug, ixekizumab, reduced the signs and symptoms of active psoriatic arthritis in patients more than a placebo did in a late-stage trial. […]